429 related articles for article (PubMed ID: 33537098)
21. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.
Zhou H; Qin Y; Ji S; Ling J; Fu J; Zhuang Z; Fan X; Song L; Yu X; Chiao PJ
Oncogene; 2018 Feb; 37(7):912-923. PubMed ID: 29059173
[TBL] [Abstract][Full Text] [Related]
22. Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10).
Li H; Yang AL; Chung YT; Zhang W; Liao J; Yang GY
Carcinogenesis; 2013 Sep; 34(9):2090-8. PubMed ID: 23689354
[TBL] [Abstract][Full Text] [Related]
23. CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma.
Morita T; Kodama Y; Shiokawa M; Kuriyama K; Marui S; Kuwada T; Sogabe Y; Matsumori T; Kakiuchi N; Tomono T; Mima A; Ueda T; Tsuda M; Yamauchi Y; Nishikawa Y; Sakuma Y; Ota Y; Maruno T; Uza N; Nagasawa T; Chiba T; Seno H
Cancer Res; 2020 Oct; 80(19):4058-4070. PubMed ID: 32606001
[TBL] [Abstract][Full Text] [Related]
24. The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer.
Nie H; Huang PQ; Jiang SH; Yang Q; Hu LP; Yang XM; Li J; Wang YH; Li Q; Zhang YF; Zhu L; Zhang YL; Yu Y; Xiao GG; Sun YW; Ji J; Zhang ZG
Theranostics; 2021; 11(8):3898-3915. PubMed ID: 33664869
[TBL] [Abstract][Full Text] [Related]
25. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
Zhang S; Chung WC; Xu K
Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
[TBL] [Abstract][Full Text] [Related]
26. Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.
Weng CC; Hsieh MJ; Wu CC; Lin YC; Shan YS; Hung WC; Chen LT; Cheng KH
Mol Cancer; 2019 May; 18(1):96. PubMed ID: 31109321
[TBL] [Abstract][Full Text] [Related]
27. Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes.
Li A; Morton JP; Ma Y; Karim SA; Zhou Y; Faller WJ; Woodham EF; Morris HT; Stevenson RP; Juin A; Jamieson NB; MacKay CJ; Carter CR; Leung HY; Yamashiro S; Blyth K; Sansom OJ; Machesky LM
Gastroenterology; 2014 May; 146(5):1386-96.e1-17. PubMed ID: 24462734
[TBL] [Abstract][Full Text] [Related]
28. Moderate alcohol intake promotes pancreatic ductal adenocarcinoma development in mice expressing oncogenic Kras.
Asahina K; Balog S; Hwang E; Moon E; Wan E; Skrypek K; Chen Y; Fernandez J; Romo J; Yang Q; Lai K; French SW; Tsukamoto H
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G265-G276. PubMed ID: 31760766
[No Abstract] [Full Text] [Related]
29. TGIF1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma.
Parajuli P; Singh P; Wang Z; Li L; Eragamreddi S; Ozkan S; Ferrigno O; Prunier C; Razzaque MS; Xu K; Atfi A
EMBO J; 2019 Jul; 38(13):e101067. PubMed ID: 31268604
[TBL] [Abstract][Full Text] [Related]
30. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Lamichhane P; Messaggio F; Shi C; Dai X; Rai P; Chen X; VanSaun MN; Merchant NB
Cancer Res; 2018 Nov; 78(21):6235-6246. PubMed ID: 30154150
[TBL] [Abstract][Full Text] [Related]
31. Transcription factor NFAT5 contributes to the glycolytic phenotype rewiring and pancreatic cancer progression via transcription of PGK1.
Jiang Y; He R; Jiang Y; Liu D; Tao L; Yang M; Lin C; Shen Y; Fu X; Yang J; Li J; Huo Y; Hua R; Liu W; Zhang J; Shen B; Zhang Z; Sun Y
Cell Death Dis; 2019 Dec; 10(12):948. PubMed ID: 31827081
[TBL] [Abstract][Full Text] [Related]
32. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression.
Hu T; Shukla SK; Vernucci E; He C; Wang D; King RJ; Jha K; Siddhanta K; Mullen NJ; Attri KS; Murthy D; Chaika NV; Thakur R; Mulder SE; Pacheco CG; Fu X; High RR; Yu F; Lazenby A; Steegborn C; Lan P; Mehla K; Rotili D; Chaudhary S; Valente S; Tafani M; Mai A; Auwerx J; Verdin E; Tuveson D; Singh PK
Gastroenterology; 2021 Nov; 161(5):1584-1600. PubMed ID: 34245764
[TBL] [Abstract][Full Text] [Related]
33. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X
J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
[TBL] [Abstract][Full Text] [Related]
34. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
Xie F; Li C; Zhang X; Peng W; Wen T
Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
[TBL] [Abstract][Full Text] [Related]
35. CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth.
Wang VM; Ferreira RMM; Almagro J; Evan T; Legrave N; Zaw Thin M; Frith D; Carvalho J; Barry DJ; Snijders AP; Herbert E; Nye EL; MacRae JI; Behrens A
Nat Cell Biol; 2019 Nov; 21(11):1425-1435. PubMed ID: 31685994
[TBL] [Abstract][Full Text] [Related]
36. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
Nimmakayala RK; Leon F; Rachagani S; Rauth S; Nallasamy P; Marimuthu S; Shailendra GK; Chhonker YS; Chugh S; Chirravuri R; Gupta R; Mallya K; Prajapati DR; Lele SM; C Caffrey T; L Grem J; Grandgenett PM; Hollingsworth MA; Murry DJ; Batra SK; Ponnusamy MP
Oncogene; 2021 Jan; 40(1):215-231. PubMed ID: 33110235
[TBL] [Abstract][Full Text] [Related]
37. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
[TBL] [Abstract][Full Text] [Related]
38. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N
Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777
[TBL] [Abstract][Full Text] [Related]
39. Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting.
Cheung PF; Neff F; Neander C; Bazarna A; Savvatakis K; Liffers ST; Althoff K; Lee CL; Moding EJ; Kirsch DG; Saur D; Bazhin AV; Trajkovic-Arsic M; Heikenwalder MF; Siveke JT
Cancer Res; 2018 Sep; 78(17):4997-5010. PubMed ID: 29844119
[TBL] [Abstract][Full Text] [Related]
40. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
